Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, November 15, 2022
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
Mon, November 14, 2022
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
Mani Foroohar Maintained (ABEO) at Hold with Increased Target to $6 on, Nov 14th, 2022
Mani Foroohar of SVB Leerink, Maintained "Abeona Therapeutics Inc." (ABEO) at Hold with Increased Target from $5 to $6 on, Nov 14th, 2022.
Mani has made no other calls on ABEO in the last 4 months.
There is 1 other peer that has a rating on ABEO. Out of the 1 peers that are also analyzing ABEO, 0 agree with Mani's Rating of Hold.
This is the rating of the analyst that currently disagrees with Mani
- Kristen Kluska of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $40 on, Tuesday, November 8th, 2022
